Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
ESC Heart Failure|June 25, 2022
Variation in heart rate range by 24-h Holter monitoring predicts heart failure in patients with atrial fibrillationJun Oikawa, Hidehira Fukaya, Shunsuke Ishii, et al.
Journal of Vascular Research|November 4, 2024
Rivaroxaban as a Protector of Oxidative Stress-Induced Vascular Endothelial Glycocalyx Damage via the IQGAP1/PAR1-2/PI3K/Akt PathwayLisa Kitasato, Minako Yamaoka-Tojo, Toshiyuki Iwaya, et al.
Heart and Vessels|August 13, 2015
Teneligliptin improves left ventricular diastolic function and endothelial function in patients with diabetesTakehiro Hashikata, Minako Yamaoka-Tojo, Ryota Kakizaki, et al.
Heart and Vessels|April 8, 2016
Ezetimibe enhances and stabilizes anticoagulant effect of warfarinTakehiro Hashikata, Minako Yamaoka-Tojo, Ryota Kakizaki, et al.
Heart and Vessels|February 25, 2017
Effects on bone metabolism markers and arterial stiffness by switching to rivaroxaban from warfarin in patients with atrial fibrillationSayaka Namba, Minako Yamaoka-Tojo, Ryota Kakizaki, et al.
Journal of Atherosclerosis and Thrombosis|August 22, 2017
Lower Level of Low Density Lipoprotein Cholesterol is Associated with a Higher Increase in the Fractional Flow Reserve in Patients with Fixed-dose RosuvastatinTakehiro Hashikata, Taiki Tojo, Yusuke Muramatsu, et al.
Clinical Cardiology|April 24, 2025
The Role of Esaxerenone in the Continuum of Heart Failure With Preserved Ejection Fraction: Insights From a Prospective Observational StudyTakashi Naruke, Miho Hashimura-Kakogawa, Yoichi Suzuki, et al.
Nature Communications|February 28, 2017
Amotl1 mediates sequestration of the Hippo effector Yap1 downstream of Fat4 to restrict heart growthChiara V Ragni, Nicolas Diguet, Jean-François Le Garrec, et al.
Pageof 2